19,827.1
(54.34)
(0.27%)
08 May , 2026 | 04:14 PM
Open
19,726.1
Prev. Close
19,772.75
Market Cap.
₹0
Div Yield
0
PE
0
PB
0
19,710.45
19,940.5
Performance
One Week (%)
4.05
One Month (%)
11.39
One Year (%)
-
YTD (%)
11.14
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,700 | 26,880 | 26,550 | 11,131 |
Cipla Ltd | 1,347 | 1,366.7 | 1,341.3 | 10,44,824 |
Glaxosmithkline Pharmaceuticals Ltd | 2,476.9 | 2,504.9 | 2,441 | 68,013 |
J B Chemicals & Pharmaceuticals Ltd | 2,149.8 | 2,164 | 2,134.9 | 1,35,870 |
Pfizer Ltd | 4,818.8 | 4,850 | 4,756.3 | 17,742 |
Jubilant Pharmova Ltd | 1,008.2 | 1,019.9 | 980 | 1,40,406 |
Apollo Hospitals Enterprise Ltd | 8,097 | 8,115 | 7,812.5 | 9,22,866 |
Dr Reddys Laboratories Ltd | 1,293.9 | 1,310.2 | 1,290 | 9,64,903 |
Lupin Ltd | 2,379.5 | 2,475 | 2,347.9 | 32,07,239 |
Torrent Pharmaceuticals Ltd | 4,380.8 | 4,398.4 | 4,336.7 | 1,16,850 |
Ipca Laboratories Ltd | 1,552.6 | 1,610.5 | 1,545.6 | 2,47,633 |
Neuland Laboratories Ltd | 17,666 | 17,765 | 17,222 | 89,796 |
Sun Pharmaceutical Industries Ltd | 1,847.9 | 1,857.5 | 1,819.2 | 28,37,885 |
Caplin Point Laboratories Ltd | 1,856.3 | 1,870.6 | 1,845.5 | 54,449 |
Aurobindo Pharma Ltd | 1,487.3 | 1,513.4 | 1,480.1 | 10,18,078 |
Natco Pharma Ltd | 1,174.7 | 1,218 | 1,152.1 | 13,37,529 |
Wockhardt Ltd | 1,606.5 | 1,649 | 1,600.3 | 11,09,475 |
Granules India Ltd | 752.95 | 761.4 | 738 | 9,89,643 |
Ajanta Pharma Ltd | 3,035 | 3,095 | 3,027.7 | 55,924 |
Poly Medicure Ltd | 1,652.1 | 1,684.9 | 1,648 | 57,575 |
Gland Pharma Ltd | 1,904.4 | 1,922.7 | 1,866.2 | 2,72,307 |
Biocon Ltd | 380.4 | 396.4 | 377.25 | 56,79,695 |
Emcure Pharmaceuticals Ltd | 1,643 | 1,675 | 1,630 | 2,63,230 |
Alkem Laboratories Ltd | 5,585.5 | 5,665.5 | 5,550 | 55,727 |
Glenmark Pharmaceuticals Ltd | 2,366.4 | 2,384.9 | 2,315.8 | 7,02,435 |
Zydus Lifesciences Ltd | 940.05 | 953 | 935.55 | 6,44,125 |
Divis Laboratories Ltd | 6,710.5 | 6,759 | 6,675 | 1,55,071 |
Max Healthcare Institute Ltd | 1,012.5 | 1,024.6 | 1,007.4 | 18,35,293 |
Fortis Healthcare Ltd | 952.35 | 966.7 | 947 | 22,11,990 |
Syngene International Ltd | 458.1 | 469.9 | 456.15 | 6,50,201 |
Anthem Biosciences Ltd | 784.65 | 805 | 779.45 | 4,29,574 |
Global Health Ltd | 1,200.6 | 1,214.9 | 1,182.8 | 2,27,835 |
Krishna Institute of Medical Sciences Ltd | 717.6 | 721.2 | 705.65 | 3,64,830 |
Rainbow Childrens Medicare Ltd | 1,304.5 | 1,335 | 1,276.6 | 8,02,279 |
Mankind Pharma Ltd | 2,430.8 | 2,464.9 | 2,377.8 | 10,78,929 |
Dr Lal Pathlabs Ltd | 1,649.8 | 1,660 | 1,551.9 | 8,85,886 |
Indegene Ltd | 530 | 535 | 528.1 | 1,55,892 |
Narayana Hrudayalaya Ltd | 1,820.3 | 1,884 | 1,814 | 3,65,040 |
Laurus Labs Ltd | 1,228.3 | 1,237.9 | 1,206 | 19,58,542 |
ERIS Lifesciences Ltd | 1,386.1 | 1,410 | 1,381.6 | 49,771 |
Sai Life Sciences Ltd | 1,115.6 | 1,124 | 1,080 | 5,37,579 |
Aster DM Healthcare Ltd | 742.4 | 748.15 | 730.1 | 6,98,355 |
Concord Biotech Ltd | 1,173.9 | 1,202.4 | 1,168 | 1,55,756 |
Acutaas Chemicals Ltd | 2,734.3 | 2,759 | 2,700 | 2,68,791 |
Cohance Lifesciences Ltd | 488.2 | 502.35 | 481 | 23,38,347 |
Vijaya Diagnostic Centre Ltd | 1,278.9 | 1,299.9 | 1,223.3 | 12,57,895 |
Piramal Pharma Ltd | 179.85 | 185.47 | 178.3 | 61,84,773 |
Blue Jet Healthcare Ltd | 490.45 | 501.6 | 488.45 | 3,75,755 |
OneSource Specialty Pharma Ltd | 1,835.2 | 1,848 | 1,792.9 | 2,64,468 |
Indian benchmark indices ended sharply lower on May 8, 2026, with the Sensex dropping 516 points and Nifty closing at 24,176 amid escalating US-Iran tensions and rising crude oil prices. Banking stocks remained under heavy pressure after SBI’s weak Q4 earnings, while IT and FMCG sectors outperformed on defensive buying interest. Titan hit a 52-week high after strong results, whereas Coal India declined on stake sale concerns.
8 May 2026|06:22 PM
Gold prices extended gains on Thursday as investors closely tracked diplomatic developments between the United States and Iran, while awaiting key US economic data for clues on Federal Reserve policy. COMEX gold futures climbed above $4,740, with spot gold holding near recent highs after a sharp rally in the previous session. A weaker US dollar, softer oil prices, and expectations of potential US rate cuts continued to support bullion demand, while domestic MCX gold prices also remained firm amid persistent geopolitical uncertainty.
7 May 2026|07:30 PM
Indian benchmark indices closed range-bound on May 7, 2026, with Nifty ending flat at 24,326 and Sensex slipping 114 points. Defence and Auto stocks outperformed on easing crude oil prices and strong earnings momentum, while IT, FMCG, and Consumer Durables witnessed profit booking amid geopolitical uncertainty and mixed Q4 results.
7 May 2026|05:20 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
